Back to 
BARCLAYS PLCCNCNSY
BARCLAYS PLCCNCNSY1 quarters
Position history for BARCLAYS PLC's holdings in PLUS THERAPEUTICS INC
Yes. Barclays holds 96 shares of CNSY (Plus Therapeutics), worth $420, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$420
Current Shares
96
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CNSY: VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD FIDUCIARY TRUST CO, STATE STREET CORP